Found: 17
Select item for more details and to access through your institution.
Axillary Management: How Much Is Too Much?
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 7, p. 735, doi. 10.1007/s11912-024-01539-0
- By:
- Publication type:
- Article
A cancer disparities curriculum in a hematology/oncology fellowship program.
- Published in:
- BMC Medical Education, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12909-023-04465-0
- By:
- Publication type:
- Article
Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 2, p. 183, doi. 10.1007/s10549-021-06368-4
- By:
- Publication type:
- Article
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231217976
- By:
- Publication type:
- Article
Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
TRIF Is a Critical Negative Regulator of TLR Agonist Mediated Activation of Dendritic Cells In Vivo.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0022064
- By:
- Publication type:
- Article
A New Adenovirus Based Vaccine Vector Expressing an Eimeria tenella Derived TLR Agonist Improves Cellular Immune Responses to an Antigenic Target.
- Published in:
- PLoS ONE, 2010, v. 5, n. 3, p. 1, doi. 10.1371/journal.pone.0009579
- By:
- Publication type:
- Article
Strengthened tumor antigen immune recognition by inclusion of a recombinant Eimeria antigen in therapeutic cancer vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 479, doi. 10.1007/s00262-015-1659-7
- By:
- Publication type:
- Article
Comparison of atrial fibrillation prevalence and in-hospital cardiovascular outcomes between patients undergoing allogeneic versus autologous hematopoietic stem cell transplantation: insights from the national inpatient sample.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65294-9
- By:
- Publication type:
- Article
Clinical markers of immunotherapy outcomes in advanced sarcoma.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10758-w
- By:
- Publication type:
- Article
Real‐world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cam4.7317
- By:
- Publication type:
- Article
Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Autoimmune Disease-Associated Variants of Extracellular Endoplasmic Reticulum Aminopeptidase 1 Induce Altered Innate Immune Responses by Human Immune Cells.
- Published in:
- Journal of Innate Immunity, 2015, v. 7, n. 3, p. 275, doi. 10.1159/000368899
- By:
- Publication type:
- Article
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00652-4
- By:
- Publication type:
- Article
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 3, p. 361, doi. 10.1007/s40487-023-00235-6
- By:
- Publication type:
- Article
An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2024, p. 1, doi. 10.1177/10732748241250189
- By:
- Publication type:
- Article